Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02555189
Title Enzalutamide With and Without Ribociclib for Metastatic, Castrate-Resistant, Chemotherapy-Naive Prostate Cancer That Retains RB Expression
Recruitment Recruiting
Gender male
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Thomas Jefferson University
Indications

prostate cancer

Therapies

Ribociclib

Enzalutamide

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Michigan Comprehensive Cancer Center Recruiting Ann Arbor Michigan 48109 United States Details
Roswell Park Cancer Institute Recruiting Buffalo New York 14263 United States Details
Memorial Sloan Kettering Cancer Center Recruiting New York New York 10065 United States Details
Thomas Jefferson University Recruiting Philadelphia Pennsylvania 19107 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field